Metformin is the most commonly prescribed Type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. In …

Novo Nordisk announced that Ozempic (semaglutide injection) is now publicly reimbursed in the province of Ontario for adults living with Type 2 …

Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD.  Republished with permission …

Latino adults have higher diabetes rates than non-Latinos, yet research shows they are less likely to correctly follow medication instructions …

A new review of Fournier Gangrene cases associated with SGLT2 diabetes drugs conducted by researchers is shedding new light on the occurrence of …

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has …

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with …

Two drugs commonly prescribed to treat type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or …